Tristel plc (AIM:TSTL)
380.00
-2.00 (-0.52%)
May 27, 2026, 5:06 PM GMT
Tristel Market Cap
Tristel has a market cap or net worth of 183.1 million as of May 27, 2026. Its market cap has decreased by -7.51% in one year.
Market Cap
183.10M
Enterprise Value
175.63M
Revenue
49.54M
Ranking
n/a
PE Ratio
23.52
Stock Price
380.00
Market Cap Chart
Since June 1, 2005, Tristel's market cap has increased from 6.91M to 183.10M, an increase of 2,550.91%. That is a compound annual growth rate of 16.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 183.10M | -8.19% |
| Dec 31, 2025 | 199.42M | -1.61% |
| Dec 31, 2024 | 202.69M | -7.08% |
| Dec 29, 2023 | 218.13M | 18.41% |
| Dec 30, 2022 | 184.21M | -14.20% |
| Dec 31, 2021 | 214.69M | -12.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.84B |
| GSK plc | 76.45B |
| Haleon | 30.46B |
| Smith & Nephew | 9.72B |
| PureTech Health | 334.94M |
| Integrated Diagnostics Holdings | 254.33M |
| NIOX Group | 249.05M |
| Scancell Holdings | 228.31M |